Skip to content
PubMed This is a summary of 58 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 58 referenced papers

Top Authors

Eduard A. A. Verhagen
University Medical Center Groningen
Leontien C.M. Kremer
Princess Máxima Center
Carlo Dionisi‐Vici
Bambino Gesù Children's Hospital
Erna M. C. Michiels
Princess Máxima Center
Kim C. van Teunenbroek
Princess Máxima Center
Brigitt C. M. Borggreve
Netherlands Comprehensive Cancer Organisation
Mattijs W. Alsem
University of Groningen
Renée L. Mulder
Princess Máxima Center
Marijke C. Kars
Utrecht University
Joanne Kurtzberg
Duke University

Top Institutions

Ranked by publications Top 10 institutions
09

Assistance Publique – Hôpitaux de Paris

Paris, France

10 papers

References

References (58)
  1. 1

    The supportive care needs of parents caring for a child with a rare disease: A scoping review.

    Pelentsov LJ, Laws TA, Esterman AJ

    Disability and health journal 2015; (8(4)):475-91.

    PMID: 25959710
  2. 2

    MRI and MRS findings in fucosidosis; a rare lysosomal storage disease.

    Ediz SS, Aralasmak A, Yilmaz TF, et al.

    Brain & development 2016; (38(4)):435-8.

    PMID: 26515723
  3. 3

    The effects of intracisternal enzyme replacement versus sham treatment on central neuropathology in preclinical canine fucosidosis.

    Kondagari GS, Fletcher JL, Cruz R, et al.

    Orphanet journal of rare diseases 2015; (10()):143 doi:10.1186/s13023-015-0357-z.

    PMID: 26537923
  4. 4

    Skeletal and Brain Abnormalities in Fucosidosis, a Rare Lysosomal Storage Disorder.

    Malatt C, Koning JL, Naheedy J

    Journal of radiology case reports 2015; (9(5)):30-8 doi:10.3941/jrcr.v9i5.2149.

    PMID: 26622931
  5. 5

    Clinical and neuroradiological approach to fucosidosis in a child with atypical presentation.

    Zubarioglu T, Kiykim E, Zeybek CA, et al.

    Annals of Indian Academy of Neurology 2015; (18(4)):471-4 doi:10.4103/0972-2327.160090.

    PMID: 26713028
  6. 6

    Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.

    Groeschel S, Kühl JS, Bley AE, et al.

    JAMA neurology 2016; (73(9)):1133-40 doi:10.1001/jamaneurol.2016.2067.

    PMID: 27400410
  7. 7

    The supportive care needs of parents with a child with a rare disease: results of an online survey.

    Pelentsov LJ, Fielder AL, Laws TA, Esterman AJ

    BMC family practice 2016; (17()):88 doi:10.1186/s12875-016-0488-x.

    PMID: 27439905
  8. 8

    A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease.

    Wolf H, Damme M, Stroobants S, et al.

    Disease models & mechanisms 2016; (9(9)):1015-28 doi:10.1242/dmm.025122.

    PMID: 27491075
  9. 9

    Therapy Development for the Lysosomal Storage Disease Fucosidosis using the Canine Animal Model.

    Fletcher JL, Taylor RM

    Pediatric endocrinology reviews : PER 2016; (13 Suppl 1()):697-706.

    PMID: 27491218
  10. 10

    Novel mutations in the FUCA1 gene that cause fucosidosis.

    Panmontha W, Amarinthnukrowh P, Damrongphol P, et al.

    Genetics and molecular research : GMR 2016; (15(3)) doi:10.4238/gmr.15038733.

    PMID: 27706744
  11. 11

    Brain abnormalities in fucosidosis: transplantation or supportive therapy?

    Jiang M, Liu S, Jiang H, et al.

    Metabolic brain disease 2017; (32(2)):317-320 doi:10.1007/s11011-017-9968-5.

    PMID: 28238202
  12. 12

    Management Strategies for CLN2 Disease.

    Williams RE, Adams HR, Blohm M, et al.

    Pediatric neurology 2017; (69()):102-112 doi:10.1016/j.pediatrneurol.2017.01.034.

    PMID: 28335910
  13. 13

    Development of a new tandem mass spectrometry method for urine and amniotic fluid screening of oligosaccharidoses.

    Piraud M, Pettazzoni M, Menegaut L, et al.

    Rapid communications in mass spectrometry : RCM 2017; (31(11)):951-963 doi:10.1002/rcm.7860.

    PMID: 28370531
  14. 14

    Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency.

    McGovern MM, Dionisi-Vici C, Giugliani R, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(9)):967-974 doi:10.1038/gim.2017.7.

    PMID: 28406489
  15. 15

    Individualised advance care planning in children with life-limiting conditions.

    Loeffen EAH, Tissing WJE, Schuiling-Otten MA, et al.

    Archives of disease in childhood 2018; (103(5)):480-485 doi:10.1136/archdischild-2017-312731.

    PMID: 29127099
  16. 16

    Recalcitrant chronic rhinosinusitis in the setting of fucosidosis, a rare lysosomal storage disorder.

    Peng T, Modi VK, Pearlman AN

    International journal of pediatric otorhinolaryngology 2017; (103()):5-9 doi:10.1016/j.ijporl.2017.09.019.

    PMID: 29224764
  17. 17

    Ocular findings in a patient with fucosidosis.

    Sánchez LR, Oatts JT, Duncan JL, et al.

    American journal of ophthalmology case reports 2016; (4()):83-86 doi:10.1016/j.ajoc.2016.10.003.

    PMID: 29503934
  18. 18

    Transcriptomic analysis of FUCA1 knock-down in keratinocytes reveals new insights into the pathogenesis of fucosidosis skin lesions.

    Valero-Rubio D, Jiménez KM, Fonseca DJ, et al.

    Experimental dermatology 2018; (27(6)):663-667 doi:10.1111/exd.13532.

    PMID: 29518279
  19. 19

    [Pediatric palliative care].

    Mojžíšová M

    Casopis lekaru ceskych 2018; (157(1)):37-40.

    PMID: 29564906
  20. 20

    Newborn screening for Pompe disease: impact on families.

    Pruniski B, Lisi E, Ali N

    Journal of inherited metabolic disease 2018; (41(6)):1189-1203 doi:10.1007/s10545-018-0159-2.

    PMID: 29594646
  21. 21

    Supporting Parent Caregivers of Children with Life-Limiting Illness.

    Koch KD, Jones BL

    Children (Basel, Switzerland) 2018; (5(7)) doi:10.3390/children5070085.

    PMID: 29949926
  22. 22

    Delivering Pediatric Palliative Care: From Denial, Palliphobia, Pallilalia to Palliactive.

    Friedrichsdorf SJ, Bruera E

    Children (Basel, Switzerland) 2018; (5(9)) doi:10.3390/children5090120.

    PMID: 30200370
  23. 23

    UPLC-MS/MS Analysis of Urinary Free Oligosaccharides for Lysosomal Storage Diseases: Diagnosis and Potential Treatment Monitoring.

    Huang R, Cathey S, Pollard L, Wood T

    Clinical chemistry 2018; (64(12)):1772-1779 doi:10.1373/clinchem.2018.289645.

    PMID: 30201803
  24. 24

    Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation.

    Raymond GV, Aubourg P, Paker A, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019; (25(3)):538-548 doi:10.1016/j.bbmt.2018.09.036.

    PMID: 30292747
  25. 25

    A Novel Homozygous Mutation in the FUCA1 Gene Highlighting Fucosidosis as a Cause of Dystonia: Case Report and Literature Review.

    Wali G, Wali GM, Sue CM, Kumar KR

    Neuropediatrics 2019; (50(4)):248-252 doi:10.1055/s-0039-1684052.

    PMID: 31064022
  26. 26

    Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care Network.

    Page KM, Stenger EO, Connelly JA, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019; (25(12)):e363-e374 doi:10.1016/j.bbmt.2019.09.003.

    PMID: 31499213
  27. 27

    Diagnosis and Supportive Management of Fucosidosis: A Case Report.

    Kaur A, Dhaliwal AS, Raynes H, et al.

    Cureus 2019; (11(11)):e6139 doi:10.7759/cureus.6139.

    PMID: 31886074
  28. 28

    Fucosidosis-Clinical Manifestation, Long-Term Outcomes, and Genetic Profile-Review and Case Series.

    Stepien KM, Ciara E, Jezela-Stanek A

    Genes 2020; (11(11)) doi:10.3390/genes11111383.

    PMID: 33266441
  29. 29

    A new UHPLC-MS/MS method for the screening of urinary oligosaccharides expands the detection of storage disorders.

    Semeraro M, Sacchetti E, Deodato F, et al.

    Orphanet journal of rare diseases 2021; (16(1)):24 doi:10.1186/s13023-020-01662-8.

    PMID: 33422100
  30. 30

    The Identification of a Novel Fucosidosis-Associated FUCA1 Mutation: A Case of a 5-Year-Old Polish Girl with Two Additional Rare Chromosomal Aberrations and Affected DNA Methylation Patterns.

    Domin A, Zabek T, Kwiatkowska A, et al.

    Genes 2021; (12(1)) doi:10.3390/genes12010074.

    PMID: 33435586
  31. 31

    Fucosidosis in Tunisian patients: mutational analysis and homology-based modeling of FUCA1 enzyme.

    Chkioua L, Amri Y, Chaima S, et al.

    BMC medical genomics 2021; (14(1)):208 doi:10.1186/s12920-021-01061-3.

    PMID: 34425818
  32. 32

    An unusual presentation of fucosidosis in a Chinese boy: a case report and literature review (childhood fucosidosis).

    Mao SJ, Zhao J, Shen Z, Zou CC

    BMC pediatrics 2022; (22(1)):403 doi:10.1186/s12887-022-03414-y.

    PMID: 35820891
  33. 33

    Cryo-EM structures of human fucosidase FucA1 reveal insight into substrate recognition and catalysis.

    Armstrong Z, Meek RW, Wu L, et al.

    Structure (London, England : 1993) 2022; (30(10)):1443-1451.e5 doi:10.1016/j.str.2022.07.001.

    PMID: 35907402
  34. 34

    Fucosidosis: clinical and molecular findings of Turkish patients.

    Şanlı ME, Uysal S

    The Turkish journal of pediatrics 2022; (64(4)):795-803.

    PMID: 36082656
  35. 35

    Late Effects in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation for Nonmalignant Diseases: Proxy- and Patient-Reported Outcomes.

    Bense JE, Haverman L, von Asmuth EGJ, et al.

    Transplantation and cellular therapy 2023; (29(3)):186.e1-186.e10 doi:10.1016/j.jtct.2022.12.024.

    PMID: 36587742
  36. 36

    The experience of living with Niemann-Pick type C: a patient and caregiver perspective.

    Golden E, van Gool R, Cay M, et al.

    Orphanet journal of rare diseases 2023; (18(1)):120 doi:10.1186/s13023-023-02741-2.

    PMID: 37210540
  37. 37

    Lysosomal storage diseases in the era of COVID-19: a report of an Egyptian case of alpha-fucosidosis and a summary of the lysosomal storage diseases-COVID-19 relationship.

    El-Amawy HS, Dawoud H

    The Egyptian journal of medical human genetics 2022; (23(1)):138 doi:10.1186/s43042-022-00350-5.

    PMID: 37521839
  38. 38

    Long-term outcomes in two adult siblings with Fucosidosis - Diagnostic odyssey and clinical manifestations.

    Puente-Ruiz N, Ellis I, Bregu M, et al.

    Molecular genetics and metabolism reports 2023; (37()):101009 doi:10.1016/j.ymgmr.2023.101009.

    PMID: 38053939
  39. 39

    A web-based psychological support program for caregivers of children with rare chronic diseases: a randomized controlled trial.

    Tutus D, Niemitz M, Plener PL, et al.

    Orphanet journal of rare diseases 2024; (19(1)):27 doi:10.1186/s13023-024-03029-9.

    PMID: 38281056
  40. 40

    A Dutch paediatric palliative care guideline: a systematic review and evidence-based recommendations for symptom treatment.

    van Teunenbroek KC, Mulder RL, Ahout IML, et al.

    BMC palliative care 2024; (23(1)):72 doi:10.1186/s12904-024-01367-w.

    PMID: 38481215
  41. 41

    A Dutch paediatric palliative care guideline: a systematic review and recommendations on advance care planning and shared decision-making.

    van Teunenbroek KC, Mulder RL, van Heel DAM, et al.

    BMC palliative care 2024; (23(1)):270 doi:10.1186/s12904-024-01568-3.

    PMID: 39578755
  42. 42

    The Unmet Needs of Lysosomal Storage Disorders from Early Diagnosis to Caregiving Pathways: An Italian Perspective.

    Castaman G, Linari S, Barbato A, et al.

    Journal of clinical medicine 2024; (13(22)) doi:10.3390/jcm13226981.

    PMID: 39598125
  43. 43

    Fucosidosis: A Review of a Rare Disease.

    Pekdemir B, Bechelany M, Karav S

    International journal of molecular sciences 2025; (26(1)) doi:10.3390/ijms26010353.

    PMID: 39796208
  44. 44

    Early Severe Cortical Involvement and Novel FUCA1 Mutations in a Pediatric Fucosidosis Case.

    de la Peña MJ, López-Martín S, Fernández-Mayoralas DM, et al.

    Molecular genetics & genomic medicine 2025; (13(2)):e70070 doi:10.1002/mgg3.70070.

    PMID: 39865383
  45. 45

    A Dutch clinical practice guideline for paediatric palliative care: a systematic review and recommendations on psychosocial care including preloss and bereavement care.

    van Teunenbroek KC, Mulder RL, Verhagen AAE, et al.

    BMC palliative care 2025; (24(1)):147 doi:10.1186/s12904-025-01763-w.

    PMID: 40410812
  46. 46

    What Constitutes High-Quality Paediatric Palliative Care? A Qualitative Exploration of the Perspectives of Children, Young People, and Parents.

    Braybrook D, Coombes L, Scott HM, et al.

    The patient 2025; (18(5)):539-561 doi:10.1007/s40271-025-00744-8.

    PMID: 40415057
  47. 47

    Parental Experiences of Receiving a Rare Genetic Disease Diagnosis for Their Child on Diagnosis Day.

    Bullock I, Malone KF, Turnwald A

    American journal of medical genetics. Part A 2026; (200(1)):67-76 doi:10.1002/ajmg.a.64223.

    PMID: 40820471
  48. 48

    Deciphering α-L-Fucosidase Activity Contribution in Human and Mouse: Tissue α-L-Fucosidase FUCA1 Meets Plasma α-L-Fucosidase FUCA2.

    Bäumges H, Jelinek S, Lange H, et al.

    Cells 2025; (14(17)) doi:10.3390/cells14171355.

    PMID: 40940767
  49. 49

    Parental psychosocial outcomes after a positive newborn screen for a lysosomal storage disorder.

    Berrios C, Gadea R, Strenk M, et al.

    Molecular genetics and metabolism 2025; (146(3)):109235 doi:10.1016/j.ymgme.2025.109235.

    PMID: 41005062
  50. 50

    Palliative Care for Children and Adults With Inherited Metabolic Disease in Europe: An Underutilised Service for Supportive Treatment and Care.

    Lee A, Bliksrud YT, Onali M, et al.

    Journal of inherited metabolic disease 2025; (48(6)):e70095 doi:10.1002/jimd.70095.

    PMID: 41137497
  51. 51

    Community-based pediatric palliative care: a systematic review of structures, processes, and outcomes.

    Acuña-Caicedo SA, González-Brossard AG, Pérez-González LE, et al.

    Jornal de pediatria 2026; (102(2)):101510 doi:10.1016/j.jped.2026.101510.

    PMID: 41633533
  52. 52

    Novel FUCA1 variants in two families, including the first report of a contiguous gene deletion syndrome involving FUCA1 and HMGCL.

    Kılıç M, Yıldız H, Dinçsoy Bir F

    The Turkish journal of pediatrics 2025; (67(6)):896-903 doi:10.24953/turkjpediatr.2025.6009.

    PMID: 41636194
  53. 53

    Metachromatic leukodystrophy (MLD) in France: the views of family caregivers on the diagnosis of the disease, its daily burden on their child, and the whole family.

    Yazbeck E, Barth M, Boyer A, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2026; (33(3)):105483 doi:10.1016/j.arcped.2026.105483.

    PMID: 41760509
  54. 54

    Glycoproteinoses: Clinical features, therapeutic landscape, and regulatory pathways in rare lysosomal disorders.

    Casazza K, Kimonis V, Whitley CB, Jarnes JR

    Molecular genetics and metabolism 2026; (148(2)):110129 doi:10.1016/j.ymgme.2026.110129.

    PMID: 42008923
  55. 55

    Neurodegenerative Diseases in Children: A Comprehensive Review.

    Ailioaie C, Ailioaie LM, Stan CI, et al.

    International journal of molecular sciences 2026; (27(9)) doi:10.3390/ijms27094096.

    PMID: 42123674
  56. 56

    Case Report: A rare case of fucosidosis caused by a novel homozygous pathogenic variant in the FUCA1 gene within a 17.2 Mb region of homozygosity.

    Wang H, Xing W

    Frontiers in medicine 2026; (13()):1573922 doi:10.3389/fmed.2026.1573922.

    PMID: 42454116
  57. 57

    Longitudinal Evolution of Neuroimaging Findings in Fucosidosis: Expanding the Neuroradiologic Spectrum.

    Nikam R, Eghbal A, Sanger T, Garavatti E

    Cureus 2026; (18(7)):e112739 doi:10.7759/cureus.112739.

    PMID: 42603069
  58. 58

    Early Hematopoietic Stem Cell Transplantation in Type 1 Fucosidosis: Reversal of Central Tegmental Tract Abnormalities.

    Palaz M, Taşkın A, Özpınar E, et al.

    Pediatric transplantation 2026; (30(10)):e70502 doi:10.1111/petr.70502.

    PMID: 42888855